 |
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Product: | Tirzepatide | Other Name: | LY3298176 |
|---|---|---|---|
| CAS NO.: | 2023788-19-2 | Grade: | Phamaceutical Grade |
| Delivery: | 100% | Minimum Order: | 1 Box (10 Vials) |
| Dosage: | 10mg, 15mg And 30mg Per Vial | Molecular Weight: | 4813.45 |
FDA Approved in May 2022 Peptide Tirzepatide 10mg 15mg Dosage Vials
Product desciption:
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, which is FDA-approved for treating type 2 diabetes mellitus. It is important to note that tirzepatide is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Tirzepatide is a GIP receptor and GLP-1 receptor agonist, leading to significantly improved glycemic control in type 2 diabetics and significant weight reduction.[1]
The FDA approved Tirzepatide in May 2022. Tirzepatide can also be used off-label for treating obesity. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications like semaglutide.[2] It is a once-a-week subcutaneous injectable medication with incremental dose increases.
Related products:
| GH 10iu 191AA | GH Fragment 176-191 | Adipotide |
| Melanotan II | Tirzepatide | Epithalon |
| Growth hormone | KPV | Oxytocin 2 |
| IGF1-LR3 | PT-141 | |
| HCG 5000iu Livzlon brand | P21 peptide | GHK-CU |
| HCG 5000iu | BPC-157 | Fox04 dri |
| TB-500 | CJC-1295 | DSIP |
| Hexarelin | HMG 75iu | AOD9604 |
| Ipamorelin | Sermorelin | MGF |
| Selank | Semaglutide | Peg-mgf |
| Semax | Tesamorelin | EPO 3000iu |
| Thymalin | Thymosin alpha | Follistatin 344 |
| GHRP2 | GHRP6 | Kisspeptin-10 Peptide |
| Gondorelin | IGF-1 DES | Dermorphin |
| IGF-LR3 | Melanotan | ACE-031 |
| Mots-C | Myostatin | AICAR |
| Please contact us for more products | ||
Product Photos:
Certifications:
Company:
FAQ:
Contact Person: jason
Tel: +86 17792557883
